Kelly D. Deck
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inhibrx Biosciences, Inc. (INBX) | C.P.A. Chief Financial Officer | $493,485 | $923,696 |
| 2024 | Inhibrx Biosciences, Inc. (INBX) | C.P.A. Chief Financial Officer | $460,100 | $4,267,254 |
| 2023 | Inhibrx Biosciences, Inc. (INBX) | C.P.A. Chief Financial Officer | $430,000 | $1,148,899 |
Recent activity
No call appearances or filed executive changes recorded yet.